-
-
Imatinib mesylate
Bcr-Abl
-
Dasatinib
Bcr-Abl, SRC, PDGFR-Beta
-
-
-
-
-
-
-
-
-
Bortezomib
Inhibit chymotrypsin-like activity of 26S proteosome
-
-
-
Combretastatin
Binds to tubulin
-
Zoledronic
Inhibit bone matrix-degrading proteinases
-
-
-
Octreotide
Inhibit GnRH receptor
-
Estramustine
form aziridinium ion
-
-
-
-
-
Letrozole
- non-steroidal
- triazole ring + heme iron of aromatase enzyme
-
-
Denileukin diftitox
Recombinant IL-2 + diphtheria toxin
-
Rituximab
CD20 Ag of B-lymphocytes
-
Trastuzumab
ADCC overexpressing HER2
-
Bevacizumab
Inhibit VEGF (IgG1)
-
Panitumumab
Inhibit EGFR (IgG2)
-
Cetuximab
Inhibit EGFR (IgG1)
-
Edrocolomab
Inhibit EpCAM
-
-
Ibritumomab
Inhibit CD20 Antigen on B cells
-
Toxitumomab
CD20 of B cells
-
Anti-PSMA mAb
- Deimmunized murine IgG2
- Against PSMA
|
|